Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
CSL Limited (ASX:CSL) has experienced one of its sharpest share price declines in recent years, with the stock falling almost 25% over the past month after management downgraded FY26 expectations and announced substantial additional asset impairments.
Neuren Pharmaceuticals Limited (ASX:NEU) has attracted renewed market attention after its shares climbed more than 13% over the past month, supported by rising DAYBUE sales, growing royalty income and progress across its neurological disorder treatment pipeline.
Trajan Group Holdings Limited (ASX:TRJ) released a trading update on 27 May 2026 outlining operational progress across its global business while cautioning investors about the likely effect of currency movements on its FY26 reported results. The update prompted a sharp reaction in the market, …
Shares in Cryosite Limited (ASX:CTE) released a trading update covering the 10 months to April 30, 2026. The stable share price reflects the market's familiarity with Cryosite's consistent financial performance trajectory, with the disclosed metrics — 22% revenue growth and 28% EBITDA growth — …
Shares in Recce Pharmaceuticals Limited (ASX:RCE) advanced AUD 0.04 or 7.62% to AUD 0.56 on May 27, 2026, following the company's announcement of a non-binding term sheet for a 10-year exclusive licensing arrangement covering its R327 Topical Gel across the Middle East and North …
Imricor Medical Systems Inc (ASX: IMR) has announced that it has secured an ASX waiver from multiple periodic reporting obligations after officially becoming a US public reporting company.
On 27 May 2026, Australian Clinical Labs Limited (ASX:ACL) lodged an Appendix 3C – Notification of buy-back as an update announcement under the type “daily buy-back notification”. The announcement covers the Company’s ordinary fully paid shares, identified by the ASX security code ACL, and …
Shares in 4DMedical (ASX:4DX) moved higher on May 27, with the stock rising 5.4% to $3.50 after the company announced publication of new peer-reviewed clinical data supporting its CT:VQ™ respiratory imaging platform.
EMVision Medical Devices Ltd (ASX:EMV) shares moved modestly higher during the morning session on 27 May 2026 after the company released favourable results from an aeromedical feasibility and usability study involving its First Responder Brain Scanner.
Aurora Labs Limited (ASX:A3D) has taken the next formal step in its relationship with MBDA, the European multi-national defence group jointly owned by Airbus, BAE Systems, and Leonardo. The Teaming Agreement announced on 27 May 2026 replaces the non-binding Memorandum of Understanding signed in …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…